New Product Briefs
This article was originally published in The Gray Sheet
FDA approves St. Jude's Brio deep brain stimulator for Parkinson's and essential tremor. The agency also approves Aesculap's activL artificial disc and said Cerapedics' i-Factor bone graft review will proceed without an advisory panel.
You may also be interested in...
Cerapedics' i-Factor peptide-enhanced bone graft will be used to treat degenerative cervical disc disease, the first bone graft product PMA-approved for that indication, the company says.
St. Jude Medical will begin enrollment by July for a pivotal study of its Cool Path Duo/Safire BLU Duo irrigated radiofrequency energy-based catheter ablation system for treatment of atrial fibrillation, the firm said during its Feb. 5 annual investor day
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.